OTC Healthcare in Mexico
Euromonitor International's OTC Healthcare in Mexico market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 128 | Publication date: Aug 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
The OTC industry recovers in 2007
A number of factors contributed to the good performance of the OTC healthcare market in Mexico in 2007, after a slight slowdown in growth in 2006. The strongest boost came from the recovery of the cough, cold and allergy (hay fever) remedies sector, due to a long cold winter, which led to a high incidence of coughs and colds among the population. Another reason for the strong growth was an end to the upheaval surrounding the use of pseudoephedrine as an active ingredient, with OTC medications starting to use phenylephrine as a substitute. The second largest sector of the OTC healthcare market, digestive remedies, also made a significant contribution to growth in sales of OTC healthcare. Unfortunately, the extensive flood disaster in the state of Tabasco in late 2007 gave a boost to demand for these products, due to a high incidence of diarrhoea, stomach infections and dehydration.
Generics set to make an impact on the market
In something of a surprising move, in early 2007, Wal-Mart de México announced the introduction of Medi-Mart, a line of generics manufactured by various laboratories and retailed under the same private label brand. These medications are being sold at prices no higher than Mx$39, and can be found in all the store formats owned by the group, such as Sam’s Club, Wal-Mart Supercenter, Bodega Aurrerá, Superama and even Vips full-service restaurants. Branded products in the analgesics, cough and cold remedies and digestive remedies sectors are expected to face more competition due to the introduction of this new line of generics.
One company alters the competitive environment
Significant changes in market share across almost all sectors have been caused by the entrance and strengthening position of brands manufactured by Genomma Lab. This Mexican company is altering the dynamics of some OTC healthcare subsectors by means of aggressive and frequent advertising campaigns. 2007 saw the competitive environment change in digestive remedies, medicated skin products, and calming and sleeping products, in particular. This has added to the pressure on the major pharmaceutical companies, which are already having to adjust to the challenge created by generics. Nevertheless, in some sectors, Mexican consumers continue to prefer well-established and traditional brands, for example in analgesics and cough, cold and allergy remedies.
“Visitadores médicos” are finding hurdles to their promotional activities
It is common practice for the major pharmaceuticals companies to employ sales representatives – known as “visitadores medicos” – to promote brands directly to physicians, typically through visiting well-known private hospitals. However, these hospitals are now reportedly levying a fee on each laboratory to allow the entrance of their respective “visitadores medicos”, leading to disputes between hospitals and manufacturers. This change in the hospitals’ policy presents a barrier to the major companies in terms of their distribution of free samples, which is a key promotional activity.
Bad eating habits and increased stress will foster greater sales
Most of the OTC healthcare sectors are predicted to see moderate growth over the forecast period, with the best performances being seen in calming and sleeping products and digestive remedies. A deterioration in eating habits, leading to an increased incidence of acid reflux, will boost sales of digestive remedies, whilst growth in calming and sleeping products will be driven by consumers’ increasingly hectic lifestyles, leading to higher levels of stress and insomnia.
Table of contents
OTC HEALTHCARE IN MEXICO : MARKET INSIGHT
EXECUTIVE SUMMARY
The OTC industry recovers in 2007
Generics set to make an impact on the market
One company alters the competitive environment
“Visitadores médicos” are finding hurdles to their promotional activities
Bad eating habits and increased stress will foster greater sales
KEY TRENDS AND DEVELOPMENTS
Medi-Mart triggers the growth of generics
Generics play a key role in competitive environment
Smuggling, counterfeiting and expired medicines are a serious threat to the industry
The pharmaceuticals industry to remain closed – for now, at least
Major noise over the pseudoephedrine issue
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 OTC Healthcare Company Shares by Value 2003-2007
Table 6 OTC Healthcare Brand Shares by Value 2004-2007
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Generics
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - MEXICO
BAYER DE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Bayer de México SA de CV: Key Facts
Summary 3 Bayer de México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 Bayer de México SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 5 Bayer de México SA de CV: Competitive Position 2007
BOEHRINGER INGELHEIM PROMECO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 7 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2007
FARMACIAS SIMILARES SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Farmacias Similares SA de CV: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Farmacias Similares SA de CV: Competitive Position 2007
GLAXOSMITHKLINE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 11 GlaxoSmithKline México SA de CV: Key Facts
Summary 12 GlaxoSmithKline México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 GlaxoSmithKline México SA de CV: Competitive Position 2007
LABORATORIOS LIOMONT SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Laboratorios Liomont SA de CV: Key Facts
Summary 15 Laboratorios Liomont SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 16 Laboratorios Liomont SA de CV: Production Statistics 2006
Summary 17 Laboratorios Liomont SA de CV: Production Capacity by Format
COMPETITIVE POSITIONING
Summary 18 Laboratorios Liomont SA de CV: Competitive Position 2007
MERCK-MéXICO SA - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Merck-México SA: Key Facts
Summary 20 Merck-México SA: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 21 Merck-México SA: Competitive Position 2007
NOVARTIS FARMACéUTICA SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 22 Novartis Farmacéutica SA de CV: Key Facts
Summary 23 Novartis Farmacéutica SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 Novartis Farmacéutica SA de CV: Competitive Position 2007
PFIZER SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Pfizer SA de CV: Key Facts
Summary 26 Pfizer SA de CV: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 27 Pfizer SA de CV: Competitive Position 2007
WYETH SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 28 Wyeth SA de CV: Key Facts
Summary 29 Wyeth SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 30 Wyeth SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 31 Wyeth SA de CV: Competitive Position 2007
ANALGESICS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2002-2007
Table 12 Sales of Analgesics by Subsector: % Value Growth 2002-2007
Table 13 Herbal vs Standard Topical Analgesics 2002-2007
Table 14 Analgesics Company Shares by Value 2003-2007
Table 15 Analgesics Brand Shares by Value 2004-2007
Table 16 Forecast Sales of Analgesics by Subsector: Value 2007-2012
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007
Table 20 Sales of Decongestants by Type: Value 2002-2007
Table 21 Sales of Decongestants by Type: % Value Growth 2002-2007
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2002-2007
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012
DIGESTIVE REMEDIES IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 29 Sales of Digestive Remedies by Subsector: Value 2002-2007
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2002-2007
Table 31 Herbal vs Standard Digestive Remedies 2002-2007
Table 32 Digestive Remedies Company Shares by Value 2003-2007
Table 33 Digestive Remedies Brand Shares by Value 2004-2007
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2007-2012
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2007-2012
MEDICATED SKIN CARE IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 36 Sales of Medicated Skin Care by Subsector: Value 2002-2007
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007
Table 38 Herbal vs Standard Medicated Skin Care 2002-2007
Table 39 Medicated Skin Care Company Shares by Value 2003-2007
Table 40 Medicated Skin Care Brand Shares by Value 2004-2007
Table 41 Acne Treatments Brand Shares by Value 2004-2007
Table 42 Hair Loss Treatments Brand Shares by Value 2004-2007
Table 43 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012
Table 44 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012
VITAMINS AND DIETARY SUPPLEMENTS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: Value 2002-2007
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2002-2007
Table 47 Sales of Vitamins by Type: Value 2002-2007
Table 48 Sales of Vitamins by Type: % Value Growth 2002-2007
Table 49 Sales of Dietary Supplements by Type: Value 2002-2007
Table 50 Sales of Dietary Supplements by Type: % Value Growth 2002-2007
Table 51 Folic Acid v Other B Vitamins 2004-2007
Table 52 Dietary Supplements by Positioning 2006-2007
Table 53 Vitamins and Dietary Supplements Company Shares by Value 2003-2007
Table 54 Vitamins and Dietary Supplements Brand Shares by Value 2004-2007
Table 55 Vitamins Brand Shares by Value 2004-2007
Table 56 Dietary Supplements Brand Shares by Value 2004-2007
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2007-2012
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2007-2012
NRT SMOKING CESSATION AIDS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 59 Number of Smokers by Gender 2002-2007
SECTOR DATA
Table 60 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007
Table 61 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007
Table 62 NRT Gum Flavours 2006-2007
Table 63 Smoking Cessation Aids Company Shares by Value 2003-2007
Table 64 Smoking Cessation Aids Brand Shares by Value 2004-2007
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012
Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012
EYE CARE IN MEXICO
SECTOR DATA
Table 67 Sales of Eye Care by Subsector: Value 2002-2007
Table 68 Sales of Eye Care by Subsector: % Value Growth 2002-2007
Table 69 Standard Eye Care by Type 2007
Table 70 Eye Care Company Shares by Value 2003-2007
Table 71 Eye Care Brand Shares by Value 2004-2007
Table 72 Forecast Sales of Eye Care by Subsector: Value 2007-2012
Table 73 Forecast Sales of Eye Care by Subsector: % Value Growth 2007-2012
EAR CARE IN MEXICO
SECTOR DATA
Table 74 Sales of Ear Care: Value 2002-2007
Table 75 Sales of Ear Care: % Value Growth 2002-2007
Table 76 Ear Care Company Shares by Value 2003-2007
Table 77 Ear Care Brand Shares by Value 2004-2007
Table 78 Forecast Sales of Ear Care: Value 2007-2012
Table 79 Forecast Sales of Ear Care: % Value Growth 2007-2012
ADULT MOUTH CARE IN MEXICO
SECTOR DATA
Table 80 Sales of Adult Mouth Care: Value 2002-2007
Table 81 Sales of Adult Mouth Care: % Value Growth 2002-2007
Table 82 Adult Mouth Care Company Shares by Value 2003-2007
Table 83 Adult Mouth Care Brand Shares by Value 2004-2007
Table 84 Forecast Sales of Adult Mouth Care: Value 2007-2012
Table 85 Forecast Sales of Adult Mouth Care: % Value Growth 2007-2012
CALMING AND SLEEPING PRODUCTS IN MEXICO
SECTOR DATA
Table 86 Sales of Calming and Sleeping Products: Value 2002-2007
Table 87 Sales of Calming and Sleeping Products: % Value Growth 2002-2007
Table 88 Calming and Sleeping Products Company Shares by Value 2003-2007
Table 89 Calming and Sleeping Products Brand Shares by Value 2004-2007
Table 90 Forecast Sales of Calming and Sleeping Products: Value 2007-2012
Table 91 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012
WOUND TREATMENTS IN MEXICO
SECTOR DATA
Table 92 Sales of Wound Treatments by Subsector: Value 2002-2007
Table 93 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007
Table 94 Wound Treatments Company Shares by Value 2003-2007
Table 95 Wound Treatments Brand Shares by Value 2004-2007
Table 96 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012
Table 97 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012
EMERGENCY CONTRACEPTION IN MEXICO